![Robert Dempsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 22 800 $ in data 31/08/2026
Robert J.
Dempsey is currently Chairman & Chief Executive Officer at iVeena Delivery Systems, Inc. since 2019.
He is Chief Executive Officer at Ashvattha Therapeutics Inc. He will serve as Chief Executive Officer & Executive Director at OKYO Pharma Ltd. starting in 2026.
He is Director at the International Council of Ophthalmology Foundation.
Since 2021, he is President & Director at AsclepiX Therapeutics LLC.
Formerly, Mr. Dempsey was Chief Executive Officer at TearClear Corp.
from 2020 to 2021.
He was Director at Ocuterra Therapeutics, Inc. from 2018 to 2021.
He was President at BIKAM Pharmaceuticals, Inc. He was Head-Ophthalmics Business at Shire Plc.
Mr. Dempsey completed undergraduate and MBAistration degrees at Northeastern University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,03% | 22/07/2026 | 15.000 ( 0,03% ) | 22 800 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WEST AFRICAN MINERALS CORP | Amministratore Delegato | 05/01/2026 |
iVeena Delivery Systems, Inc.
 iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology Manufactures eye drops | Amministratore Delegato | 22/10/2019 |
International Council of Ophthalmology Foundation | Direttore/Membro del Consiglio | - |
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Presidente | 17/03/2021 |
Ashvattha Therapeutics Inc
 Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
Ocuterra Therapeutics, Inc.
 Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Manufactures drug products | Direttore/Membro del Consiglio | 14/12/2021 |
TearClear Corp.
 TearClear Corp. Medical SpecialtiesHealth Technology Develops hydrogel filter to remove potentially harmful preservatives from multi-dose topical ophthalmic products used to treat chronic diseases | Amministratore Delegato | 16/03/2021 |
BIKAM Pharmaceuticals, Inc.
 BIKAM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops ophthalmic pharmaceuticals products | Presidente | - |
| SHIRE | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
BIKAM Pharmaceuticals, Inc.
BIKAM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops ophthalmic pharmaceuticals products | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Council of Ophthalmology Foundation | |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Manufactures drug products | Retail Trade |
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology Manufactures eye drops | Health Technology |
Ashvattha Therapeutics Inc
Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Commercial Services |
TearClear Corp.
TearClear Corp. Medical SpecialtiesHealth Technology Develops hydrogel filter to remove potentially harmful preservatives from multi-dose topical ophthalmic products used to treat chronic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
